Edward Atkinson

Technik-/Wissenschafts-/F&E-Leiter bei VERTEX PHARMACEUTICALS INCORPORATED

Vermögen: 12 Mio $ am 30.04.2024

58 Jahre

Health Technology

Consumer Services

Aktive Positionen von Edward Atkinson

Unternehmen	Position	Beginn	Ende
89BIO, INC.	Direktor/Vorstandsmitglied	17.02.2022	-
89BIO, INC.	Independent Dir/Board Member	17.02.2022	-
VERTEX PHARMACEUTICALS INCORPORATED	Technik-/Wissenschafts-/F&E-Leiter	29.08.2023	-
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01.07.2020	29.08.2023

Unternehmen	Position	Beginn	Ende
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01.01.2012	01.06.2020
Catalent Indiana LLC Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2011	19.09.2012

Stanford University	Doctorate Degree
Indiana University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Director/Board Member	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
89BIO, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private Unternehmen	1
Catalent Indiana LLC Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN.	Health Technology